Acting Administrator Andy Slavitt says the Fraud Prevention System has yielded a 10-to-1 return for taxpayers
An investment to fight Medicare fraud is more than paying for itself, CMS Acting Administrator Andy Slavitt announced today. The agency’s Fraud Prevention System has identified $820 million in improper payments in its first 3 years, including $454 million just in calendar year 2014, Slavitt said.
“Very few investments have a 10-to-1 return on taxpayer money,” Slavitt said. “We are proving that in a modern healthcare system you can both fight fraud and avoid creating hassles for the vast majority of physicians who simply want to get paid for services rendered.”
Good data is the key, he said. The availability of the data needed to combat fraud was made possible by the 2010 Small Business Jobs Act, and CMS has also gained tools through the Affordable Care Act. In addition to the Fraud Prevention System, the HHS and the Department of Justice has gone after individual doctors and nurses in a recent crackdown involving 46 individuals and $712 million in false billings.
Having good data reveals patterns of improper practices and allows Medicare to move quickly against providers, making referrals to law enforcement when appropriate. In its third year, the Fraud Prevention System is now creating “high yield” prevention activity, allowing CMS to move beyond the “pay and chase” model, according to Dr Shantanu Agrawal, CMS’ deputy administrator and director of the Center for Program Integrity.
As the program matures, CMS will continue to tweak its formulas to identify lower levels of improper billing, including some providers who might benefit from education in proper billing practices.
For more information, see the Center for Program Integrity.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More